Concerns with Contract Manufacturer Draw Complete Response for Allergan’s Levadex

Drug Industry Daily
A A
Allergan has received a complete response letter (CRL) for its aerosol-based migraine drug Levadex.

To View This Article:

Login

Subscribe To Drug Industry Daily